Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Nov;96(5):2348–2356. doi: 10.1172/JCI118291

Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.

A Nomura 1, K Nishikawa 1, Y Yuzawa 1, H Okada 1, N Okada 1, B P Morgan 1, S J Piddlesden 1, M Nadai 1, T Hasegawa 1, S Matsuo 1
PMCID: PMC185886  PMID: 7593622

Abstract

The kidney widely expresses membrane-associated complement regulatory proteins (membrane inhibitors of complement). The aim of this work was to evaluate the roles of these molecules in rat kidneys in vivo. To suppress functions of rat membrane inhibitors of complement, two mAbs, 512 and 6D1, were used. 5I2 and 6D1 inhibit functions of membrane inhibitors of complement at C3 level (rat Crry/p65) and C8/9 level (rat CD59), respectively. F(ab')2 fragment of 5I2 or 6D1 was perfused in the left kidneys, and perfusate was discarded from the renal vein. After perfusion, the left kidneys were connected to systemic circulation. In rats perfused with 5I2, mouse IgG was found in glomeruli, peritubular capillaries, vascular bundles, and tubules 15 min after recirculation. Binding of C3 and C5b-9 was evident in these areas. 1 d after perfusion with 5I2, cast formation, dilatation of tubular lumen, and tubular cell degeneration were observed. At day 4 through day 7, significant mononuclear cell infiltration and proximal tubule damage were observed. These changes were completely prevented by complement depletion. Rats perfused with 6D1 showed the binding of mouse IgG in the similar areas as 5I2, but C3 or C5b-9 deposition was not observed. Rats perfused with 6D1 or vehicle only did not show any pathology in the left kidneys. These results suggest that rat Crry/p65 plays protective roles against spontaneously occurring indiscriminate attack to tubulointerstitial tissues by autologous complement and that rat Crry/p65 is one of the important factors to maintain normal integrity of the kidney in rats.

Full text

PDF
2348

Images in this article

2350Image
on p.2350
2350Image
on p.2350
2350Image
on p.2350
2350Image
on p.2350
2350Image
on p.2350
2350Image
on p.2350
2351Image
on p.2351
2352Image
on p.2352
2353Image
on p.2353
2354Image
on p.2354
2354Image
on p.2354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DISCHE Z., BORENFREUND E. A new spectrophotometric method for the detection and determination of keto sugars and trioses. J Biol Chem. 1951 Oct;192(2):583–587. [PubMed] [Google Scholar]
  2. Davies A., Simmons D. L., Hale G., Harrison R. A., Tighe H., Lachmann P. J., Waldmann H. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med. 1989 Sep 1;170(3):637–654. doi: 10.1084/jem.170.3.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eddy A. A. Tubulointerstitial nephritis during the heterologous phase of nephrotoxic serum nephritis. Nephron. 1991;59(2):304–313. doi: 10.1159/000186569. [DOI] [PubMed] [Google Scholar]
  4. Foley S., Li B., Dehoff M., Molina H., Holers V. M. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur J Immunol. 1993 Jun;23(6):1381–1384. doi: 10.1002/eji.1830230630. [DOI] [PubMed] [Google Scholar]
  5. Funabashi K., Okada N., Matsuo S., Yamamoto T., Morgan B. P., Okada H. Tissue distribution of complement regulatory membrane proteins in rats. Immunology. 1994 Mar;81(3):444–451. [PMC free article] [PubMed] [Google Scholar]
  6. Gröne H. J., Weber K., Gröne E., Helmchen U., Osborn M. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol. 1987 Oct;129(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  7. Guesdon J. L., Ternynck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem. 1979 Aug;27(8):1131–1139. doi: 10.1177/27.8.90074. [DOI] [PubMed] [Google Scholar]
  8. Holguin M. H., Fredrick L. R., Bernshaw N. J., Wilcox L. A., Parker C. J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1989 Jul;84(1):7–17. doi: 10.1172/JCI114172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hostetter M. K., Gordon D. L. Biochemistry of C3 and related thiolester proteins in infection and inflammation. Rev Infect Dis. 1987 Jan-Feb;9(1):97–109. doi: 10.1093/clinids/9.1.97. [DOI] [PubMed] [Google Scholar]
  10. Hostetter M. K. The third component of complement: new functions for an old friend. J Lab Clin Med. 1993 Nov;122(5):491–496. [PubMed] [Google Scholar]
  11. Hughes T. R., Piddlesden S. J., Williams J. D., Harrison R. A., Morgan B. P. Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J. 1992 May 15;284(Pt 1):169–176. doi: 10.1042/bj2840169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ichida S., Yuzawa Y., Okada H., Yoshioka K., Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 1994 Jul;46(1):89–96. doi: 10.1038/ki.1994.247. [DOI] [PubMed] [Google Scholar]
  13. Kim Y. U., Kinoshita T., Molina H., Hourcade D., Seya T., Wagner L. M., Holers V. M. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med. 1995 Jan 1;181(1):151–159. doi: 10.1084/jem.181.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Martin B. K., Weis J. H. Functional identification of transcription control sequences of the mouse Crry gene. J Immunol. 1993 Jul 15;151(2):857–869. [PubMed] [Google Scholar]
  15. Matsuo S., Ichida S., Takizawa H., Okada N., Baranyi L., Iguchi A., Morgan B. P., Okada H. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med. 1994 Nov 1;180(5):1619–1627. doi: 10.1084/jem.180.5.1619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matsuo S., Nishikage H., Yoshida F., Nomura A., Piddlesden S. J., Morgan B. P. Role of CD59 in experimental glomerulonephritis in rats. Kidney Int. 1994 Jul;46(1):191–200. doi: 10.1038/ki.1994.259. [DOI] [PubMed] [Google Scholar]
  17. Matsuo S., Yoshida F., Yuzawa Y., Hara S., Fukatsu A., Watanabe Y., Sakamoto N. Experimental glomerulonephritis induced in rats by a lectin and its antibodies. Kidney Int. 1989 Dec;36(6):1011–1021. doi: 10.1038/ki.1989.295. [DOI] [PubMed] [Google Scholar]
  18. Molina H., Wong W., Kinoshita T., Brenner C., Foley S., Holers V. M. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med. 1992 Jan 1;175(1):121–129. doi: 10.1084/jem.175.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nath K. A., Hostetter M. K., Hostetter T. H. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest. 1985 Aug;76(2):667–675. doi: 10.1172/JCI112020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nath K. A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992 Jul;20(1):1–17. doi: 10.1016/s0272-6386(12)80312-x. [DOI] [PubMed] [Google Scholar]
  21. Nicholson-Weller A., Burge J., Fearon D. T., Weller P. F., Austen K. F. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982 Jul;129(1):184–189. [PubMed] [Google Scholar]
  22. Nishikage H., Baranyi L., Okada H., Okada N., Isobe K., Nomura A., Yoshida F., Matsuo S. The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol. 1995 Aug;6(2):234–241. doi: 10.1681/ASN.V62234. [DOI] [PubMed] [Google Scholar]
  23. Okada N., Harada R., Fujita T., Okada H. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement. J Immunol. 1989 Oct 1;143(7):2262–2266. [PubMed] [Google Scholar]
  24. Platt J. L., Michael A. F. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem. 1983 Jun;31(6):840–842. doi: 10.1177/31.6.6341464. [DOI] [PubMed] [Google Scholar]
  25. Rushmere N. K., Harrison R. A., van den Berg C. W., Morgan B. P. Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem J. 1994 Dec 1;304(Pt 2):595–601. doi: 10.1042/bj3040595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sakurada C., Seno H., Dohi N., Takizawa H., Nonaka M., Okada N., Okada H. Molecular cloning of the rat complement regulatory protein, 5I2 antigen. Biochem Biophys Res Commun. 1994 Feb 15;198(3):819–826. doi: 10.1006/bbrc.1994.1117. [DOI] [PubMed] [Google Scholar]
  27. Schainuck L. I., Striker G. E., Cutler R. E., Benditt E. P. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol. 1970 Dec;1(4):631–641. doi: 10.1016/s0046-8177(70)80061-2. [DOI] [PubMed] [Google Scholar]
  28. Schulze M., Baker P. J., Perkinson D. T., Johnson R. J., Ochi R. F., Stahl R. A., Couser W. G. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int. 1989 Jan;35(1):60–68. doi: 10.1038/ki.1989.8. [DOI] [PubMed] [Google Scholar]
  29. Seya T., Turner J. R., Atkinson J. P. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med. 1986 Apr 1;163(4):837–855. doi: 10.1084/jem.163.4.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Striker G. E., Schainuck L. I., Cutler R. E., Benditt E. P. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol. 1970 Dec;1(4):615–630. doi: 10.1016/s0046-8177(70)80060-0. [DOI] [PubMed] [Google Scholar]
  31. Sugita Y., Nakano Y., Tomita M. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J Biochem. 1988 Oct;104(4):633–637. doi: 10.1093/oxfordjournals.jbchem.a122524. [DOI] [PubMed] [Google Scholar]
  32. Takizawa H., Okada N., Okada H. Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol. 1994 Mar 15;152(6):3032–3038. [PubMed] [Google Scholar]
  33. Tolins J. P., Hostetter M. K., Hostetter T. H. Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest. 1987 May;79(5):1447–1458. doi: 10.1172/JCI112973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Watanabe N., Kamei S., Ohkubo A., Yamanaka M., Ohsawa S., Makino K., Tokuda K. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem. 1986 Aug;32(8):1551–1554. [PubMed] [Google Scholar]
  35. Zalman L. S., Wood L. M., Müller-Eberhard H. J. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6975–6979. doi: 10.1073/pnas.83.18.6975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES